Dr.Asha Deepti Choppala has obtained her doctoral and postgraduation degree in Pharmaceutical Chemistry from Andhra University. She has expertise in design and synthesis of new heterocyclic moieties, their purification and structural identification. She has published 38 research papers in reputed journals. Dr. Asha Deepti has completed a major research project sponsored by the UGC. She has successfully guided 4 Ph. D. students and 4 are currently pursuing Ph.D under her guidance.
Research Publications
-
Development and Optimization of Osimertinib-loaded Biodegradable Polymeric Nanoparticles Enhance In-vitro Cytotoxicity in Mutant EGFR NSCLC Cell Models and In-vivo Tumor Reduction in H1975 Xenograft Mice Models. AAPS PHARMSCITECH, 23(5), 2022.
-
Antimicrobial and Antitubercular Activity of novel pyrazole-4-carboxamide derivatives: Synthesis and Characterization. Journal of Applied Pharmaceutical Science, Vol.13(5), 2023
-
Synthesis, Characterization and Evaluation of Anticancer Activity of New Pyrazole-5-Carboxamide derivatives. Asian Journal of Chemistry, Vol.35(8), 2023
-
Biocompatible Osimertinib nanoliposomes coated with PEGylated hyaluronic acid enhanced tumor selectivity and cytotoxicity via CD44-mediated NSCLC targeting: Development, characterization and in-vitro biochemical studies. Journal of Applied Pharmaceutical Science, Vol. 13(7), 204-213, 2023
-
Synthesis, Characterization, Antitubercular Activity and Docking Studies of 2-(benzo[d]oxazol-2-ylthio)-1-(3-(4-fluoro-3-methyl phenyl)-5-(substituted aryl)-4,5-dihydro-1H-pyrazol-1-yl) ethenone, Journal of Young Pharmacists, 2020
Ongoing Research Projects
-
--
Expertise
-
Design and development of new heterocyclic moieties.
-
Synthesis of novel Antibacterial and Anti-inflammatory compounds and their pharmacological evaluation.
-
Purification and structural characterization of synthetic heterocyclic compounds.
Authored Books
-
--